Docosapentaenoic Acid n-6 Suppresses Macrophage Ferroptosis in Sepsis-Induced Acute Liver Injury by Targeting the ALOX15/PEBP1 Complex

Sepsis is a life-threatening reaction where the body's own immune system turns against itself in a desperate attempt to fight an infection. This chaotic response often damages healthy organs, with the liver being a frequent casualty. When the liver fails during sepsis, the chances of survival drop dramatically. For decades, doctors have struggled to find a way to stop this specific type of organ damage without causing other problems. Recent research has shifted focus to a specific way cells die called ferroptosis. Unlike other forms of cell death, ferroptosis is driven by rust-like oxidation of fats inside the cell, a process that requires iron and happens when the cell's natural antioxidant defenses run out. In the liver, a type of immune cell called a macrophage is particularly vulnerable to this rusting process. When these cells die, they release signals that worsen inflammation, creating a vicious cycle that destroys liver tissue. Understanding how to stop this rusting without shutting down the entire immune system is a major goal for modern medicine.

A team of researchers at Chongqing University has discovered a natural molecule that appears to stop this destructive cycle in its tracks. They found that a specific fat derived from linoleic acid, a common component of vegetable oils, acts as a shield for these immune cells. This molecule, known as docosapentaenoic acid n-6, or DPAn-6 for short, was shown to prevent the liver from failing in mice suffering from severe sepsis. The study, published recently, reveals that this molecule works by physically blocking a harmful interaction between two proteins inside the cell. By stopping this interaction, the molecule prevents the cell from rusting out, keeping the liver functional and the immune response under control.

The journey to this discovery began with a simple question: why does a diet rich in linoleic acid seem to protect against sepsis-induced liver injury? While linoleic acid is often discussed in the context of inflammation, the researchers suspected that its protective power came from what the body turns it into, rather than the acid itself. To find out, they fed mice a diet high in linoleic acid and then induced a severe infection similar to human sepsis. The mice on the special diet survived at much higher rates than those on a standard diet. Their livers showed far less damage, and their blood levels of inflammatory markers were significantly lower. The researchers then used advanced chemical analysis to map the fats inside the livers of these mice. They found that one specific molecule, DPAn-6, had increased the most. This suggested that DPAn-6 was the active ingredient responsible for the protection.

To confirm that DPAn-6 was indeed the hero, the scientists gave it directly to mice that had not eaten the special diet. They administered the molecule daily for several weeks before inducing the infection. The results were striking. Mice treated with DPAn-6 survived the infection far better than untreated mice. Their livers remained intact, and their blood showed signs of healthy function. The researchers also compared DPAn-6 to docosahexaenoic acid, or DHA, a well-known omega-3 fat famous for its anti-inflammatory properties. While DHA offered some protection, DPAn-6 was consistently more effective at saving lives and preserving liver tissue. This finding challenged the old idea that omega-6 fats are simply bad and omega-3 fats are simply good, suggesting instead that the specific breakdown products of these fats matter more than their broad categories.

The next step was to understand how this molecule actually worked inside the cells. The researchers focused on the liver's macrophages, the immune sentinels that were dying in large numbers during the infection. They observed that in untreated mice, these cells were undergoing ferroptosis, a process characterized by a buildup of toxic fats and a loss of the cell's ability to neutralize them. When DPAn-6 was present, the cells remained healthy. The molecule restored the levels of a crucial antioxidant enzyme called GPX4 and stopped the accumulation of iron and toxic fat byproducts. Crucially, the researchers found that if they blocked the protective effect of ferroptosis inhibitors, DPAn-6 lost its ability to calm inflammation. This proved that stopping the cell from rusting was the key to stopping the inflammation.

To find the exact target of DPAn-6, the team looked at the machinery inside the cell that drives this rusting process. They focused on a protein called ALOX15, which acts like a machine that adds oxygen to fats, turning them into the toxic compounds that kill the cell. Under normal conditions, ALOX15 works on free-floating fats. However, during sepsis, another protein called PEBP1 latches onto ALOX15. This partnership redirects the machine to attack the fats inside the cell membrane, causing the cell to self-destruct. The researchers discovered that DPAn-6 works by physically interfering with this partnership. It binds directly to ALOX15, specifically at a spot on the protein called Glu650. This binding site is the exact same spot where PEBP1 tries to attach. By occupying this space, DPAn-6 acts like a wedge, preventing PEBP1 from latching on. Without this partnership, ALOX15 cannot turn on the destructive pathway, and the cell survives.

The team proved this mechanism with rigorous precision. They created a version of the ALOX15 protein where the Glu650 spot was changed so that DPAn-6 could no longer bind to it. When they tested this modified protein in cells, DPAn-6 lost all its protective power. The cells rusted and died just as they would without the treatment. Furthermore, when they gave this modified protein to mice and then treated them with DPAn-6, the mice did not survive the infection any better than untreated mice. This confirmed that the interaction between DPAn-6 and that specific spot on the protein was essential for the protection. The researchers also checked other similar proteins and found that DPAn-6 did not affect them, showing that its action was highly specific to ALOX15.

This study provides a clear picture of how a dietary fat can be converted into a life-saving molecule. It shows that the body can turn a common nutrient into a precise tool that stops a specific type of cell death. The researchers demonstrated that DPAn-6 does not simply turn off the ALOX15 protein entirely; instead, it selectively stops it from forming a harmful partnership with PEBP1. This is a subtle but important distinction. By blocking only the destructive interaction while leaving the protein's other functions intact, the body avoids the side effects that might come from shutting down the protein completely. The findings suggest that the balance of fats in our diet can influence how our immune cells respond to severe infection, not just by providing fuel, but by creating molecules that regulate cell death at a molecular level.

While the study was conducted in mice and cells, the implications for human health are significant. Sepsis remains a leading cause of death worldwide, and current treatments often fail to stop the organ damage that follows the initial infection. This research identifies a new pathway that could be targeted with drugs or dietary strategies. The molecule DPAn-6 is naturally produced in the body, which suggests that boosting its levels or mimicking its action could be a safe and effective way to protect the liver during sepsis. The study also highlights the importance of looking beyond the broad categories of fats to understand the specific molecules they become. By understanding exactly how DPAn-6 binds to ALOX15, scientists can now design new therapies that replicate this natural protection, offering hope for patients who currently have few options. The work stands as a testament to the power of basic research in uncovering the hidden mechanisms that keep our bodies alive during their most critical moments.